RRM1 and lung adenocarcinoma: To further investigate this issue, we have carried out a multicentre phase II study to evaluate the impact of RRM1 and RRM2 mRNA expression in the tumours of lung adenocarcinoma patients treated with docetaxel/gemcitabine.